Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human P2RY4 Stable Cell Line

    [CAT#: S01YF-0923-KX18]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Protein
    P2RY4
    Target Family
    P2Y Family
    Target Protein Species
    Human
    Host Cell Type
    CHO-K1; HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    Cancer Research; Cardiovascular Research
    Related Diseases
    Arthrogryposis; Infiltrative Basal Cell Carcinoma
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    Almost all human tissues express members of the G protein-coupled P2Y receptor family, which is highly sought after as a possible treatment target for a wide range of illnesses, particularly cardiovascular and neurodegenerative disorders. Uridine 5'-triphosphate (UTP) and adenosine triphosphate (ATP) act as mediators for P2RY4 activation. P2RY4 is highly expressed throughout the body, including the heart, digestive system, skin, and central nervous system. P2RY4 is thought to control chloride secretion in the digestive system. As a result, P2RY4 antagonists are potential targets for the therapy of diarrhea, while P2RY4 agonists may be utilized to treat cystic fibrosis. Additionally, it has been suggested that P2RY4 controls how the brain produces the amyloid precursor protein (APP). P2RY4 antagonists are potential therapeutic drugs for the treatment of Alzheimer's disease since the buildup of APP in the brain is linked to the development of the condition. Although there haven't been any reports of prospective P2RY4 antagonists to date, this is a promising area for the creation of selective P2RY4 antagonists. The customized P2RY4 stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Liam

    The customized P2RY4 stable cell line can be used in antibody discovery and development. Jan 29 2023

    chat Verified Customer

    chat Amelia

    The P2RY4 cell line enable us to develop new insights into its role in disease pathology. Dec 01 2022

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 Expression patterns of p2ry4 during early development.

    From the gastrula to the tailbud stage, WISH of p2ry4. At the gastrula stage, p2ry4 was expressed throughout the developing neuroectoderm as well as the dorsal and ventral mesoderm. P2RY4 was clearly expressed in the head organizer area at stage 10.5.

    Ref: Harata, Ayano, et al. "Nucleotide receptor P2RY4 is required for head formation via induction and maintenance of head organizer in Xenopus laevis." Development, Growth & Differentiation 61.2 (2019): 186-197.

    Pubmed: 30069871

    DOI: 10.1111/dgd.12563

    Research Highlights

    Vertebrates have distinctive head structures that are mostly made up of the neural crest, placode cells, and the central nervous system. The neural induction between the organizer and the potential neuroectoderm at the early gastrula stage is what first causes these head features.
    Harata, Ayano, et al. "Nucleotide receptor P2RY4 is required for head formation via induction and maintenance of head organizer in Xenopus laevis." Development, Growth & Differentiation 61.2 (2019): 186-197.
    Pubmed: 30069871   DOI: 10.1111/dgd.12563

    In the world, hepatocellular carcinoma (HCC) is the leading cause of cancer-related death. The 5-year survival rate for HCC is remains low even though there are numerous treatment options available. Both in vitro and in vivo, emodin can stop HCC cells from proliferating.
    Zhou, Rui-sheng, et al. "Anticancer effects of emodin on HepG2 cell: evidence from bioinformatic analysis." BioMed research international 2019 (2019).
    Pubmed: 31236404   DOI: 10.1155/2019/3065818

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare